drugset / Trial / NCT06537050
A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JX2105 in Healthy Chinese Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to evaluate the safety, tolerability after administration of single dose or multiple doses, and the pharmacokinetics (PK) of single and multiple doses of JX2105 in healthy study participants.
Timeline
- Start
- 2024-07-01
- Primary completion
- 2025-01-30
- Completion
- 2025-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | JX2105 | Unknown | 10 mg | Oral |
| Comparator | JX2105 | Unknown | 30 mg | Oral |
| Comparator | JX2105 | Unknown | 90 mg | Oral |
| Comparator | JX2105 | Unknown | 180 mg | Oral |